What are the diagnostic criteria for rheumatoid arthritis?

Diagnosis of Rheumatoid Arthritis

Rheumatoid arthritis is diagnosed using the 2010 ACR/EULAR classification criteria, which require a total score of ≥6 points across four domains: joint involvement (0-5 points), serology (0-3 points), acute-phase reactants (0-1 point), and symptom duration (0-1 point), in patients with confirmed synovitis in at least one joint and no alternative diagnosis. 1

Clinical Presentation That Should Trigger Diagnostic Evaluation

• Morning stiffness lasting ≥1 hour before maximal improvement is a hallmark feature that strongly suggests RA and correlates with disease activity 2, 3
• Symmetric polyarthritis affecting small joints, particularly metacarpophalangeal (MCP) joints, proximal interphalangeal (PIP) joints, and wrists, is the characteristic distribution pattern 3, 2
• Symptom duration ≥6 weeks is an independent predictor of persistent inflammatory arthritis and a required criterion for classification 2, 4, 5
• Functional impairment in daily activities predicts progression to persistent inflammatory arthritis 4, 6

The 2010 ACR/EULAR Classification Criteria (Scoring System)

Joint Involvement (0-5 points):

• 1 large joint = 0 points
• 2-10 large joints = 1 point
• 1-3 small joints (with or without large joints) = 2 points
• 4-10 small joints (with or without large joints) = 3 points

• 10 joints (at least 1 small joint) = 5 points 1

Serology (0-3 points):

• Negative RF AND negative ACPA = 0 points
• Low-positive RF OR low-positive ACPA (≤3× upper limit of normal) = 2 points
• High-positive RF OR high-positive ACPA (>3× upper limit of normal) = 3 points 1

Acute-Phase Reactants (0-1 point):

• Normal CRP AND normal ESR = 0 points
• Abnormal CRP OR abnormal ESR = 1 point 1

Duration of Symptoms (0-1 point):

• <6 weeks = 0 points
• ≥6 weeks = 1 point 1

Essential Laboratory Testing

• RF and ACPA (anti-CCP) should both be tested simultaneously, as ACPA demonstrates approximately 90% specificity and 60% sensitivity for RA; these are predictive of both diagnosis and prognosis 4, 5, 6
• 20-30% of RA patients are seronegative (negative RF and ACPA), particularly in early disease, so negative tests do not exclude RA 4, 6, 7
• ACPA has superior prognostic value compared to RF levels; ACPA positivity better predicts RA development and severity than high RF levels, and RF levels vary considerably between measurement methods 7
• ESR and CRP should both be measured at baseline for diagnosis and prognosis, as they can be discordant and CRP can be normal in early RA 4, 5, 6

Imaging Studies

• Plain radiographs (posteroanterior views) of hands, wrists, and feet should be obtained at baseline as the gold standard initial imaging 4, 5, 3
• The presence of marginal erosions on baseline radiographs is highly predictive of RA diagnosis and persistent disease activity 4, 5
• Radiographs should be repeated within 1 year if erosions are absent initially, as their development indicates need for treatment intensification 4, 6
• MRI of hands and wrists should be considered when RA is suspected but criteria are not yet met, as it can identify early inflammatory changes and tenosynovitis 5, 4
• Ultrasound with power Doppler can identify active synovitis and is useful when patients don't meet 2010 criteria but clinical suspicion remains high 5

Critical Timing for Referral and Treatment

• Patients with suspected inflammatory arthritis must be referred to rheumatology within 6 weeks of symptom onset to prevent irreversible joint damage 5, 3, 6
• Urgent referral is warranted when any of the following are present:
  • ≥2 clinically swollen joints AND morning stiffness >30 minutes
  • Positive "squeeze test" of MCP or metatarsophalangeal joints
  • Elevated inflammatory markers (CRP or ESR)
  • Any clinical synovitis without alternative explanation 3

Predictors of Persistent/Erosive Disease

• Disease duration ≥6 weeks (Level 1b evidence) 4, 5
• Morning stiffness >30 minutes (Level 4 evidence) 4, 5
• Involvement of ≥3 joints (Level 1b evidence) 4
• Small joint involvement (wrist, MCP, PIP) (Level 4 evidence) 4, 5
• ACPA and/or RF positivity (Level 4 evidence) 4
• Presence of radiographic erosions (Level 1b evidence) 4, 5

Common Diagnostic Pitfalls to Avoid

• Do not wait for positive serology before referring or treating; seronegative RA is common and diagnosis relies primarily on clinical assessment 6, 4
• Do not dismiss atypical presentations (e.g., evening-only symptoms or asymmetric involvement in early stages) without excluding inflammatory causes 3
• Do not rely solely on CRP; ESR should also be measured as they can be discordant 6
• Do not delay DMARD initiation in patients at risk of persistent/erosive disease even if they don't yet fulfill classification criteria, as there is a critical "window of opportunity" for preventing joint destruction 5, 6

Differential Diagnosis Considerations

• All possible causes of arthritis must be systematically excluded: autoimmune (SLE, psoriatic arthritis, spondyloarthropathies), infectious, malignancy, crystalline (gout, pseudogout), and metabolic causes 4
• Additional autoantibody testing (ANA, HLA-B27) should be considered when connective tissue disease or spondyloarthropathy is suspected 4, 3
• Synovial biopsy is not routinely recommended but can provide differential diagnostic information in persistent monoarthritis 4